We aim to develop a personalized multi-scale biomechanical model of the knee that integrates joint movement (marker-based motion capture, fluoroscopy), EMG and force data with quantitative cartilage parameters derived from advanced imaging…
ID
Source
Brief title
Condition
- Joint disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The association between biomechanical patterns at baseline with progression of
structural OA-features on MRI after two years.
Secondary outcome
Evaluate test-retest reliability of the biomechanical measurement protocol and
processing pipeline.
- Assess sensitivity of the biomechanical models to changes in model
parameters.
- Validate a 3D-2D image registration algorithm.
- Assess the correlation between subchondral bone metabolism at baseline and
progression of compositional or structural OA-related features after two
years.
- Explore associations among the data collected to generate hypotheses to
inform future research.
Background summary
OA is expected to be the most prevalent disease in the Netherlands by 2040. The
knee is the most common joint affected by OA, and knee OA is responsible for
more physical disability than any other disease among older adults.
Knee OA is predominantly held to be caused by pathomechanics: biomechanical
factors that lead to increases in cartilage stress, promoting its degeneration.
Current methods used to evaluate knee biomechanics contain substantial error,
which prevents accurate estimates of cartilage stress. A more accurate and
precise measure of stress distribution throughout the cartilage tissue (instead
of the average load through the joint) would improve our ability to detect and
quantify the relationships between joint/cartilage pathomechanics and OA.
This would have substantial impact on OA research and management by making it
possible to incorporate relevant biomechanical factors into personalized
prediction models. Moreover, it would inform hypotheses about which
interventions might favourably alter biomechanics, potentially leading to
improved outcomes including slowing down the progression of OA, reducing pain,
and improving function and quality of life.
Study objective
We aim to develop a personalized multi-scale biomechanical model of the knee
that integrates joint movement (marker-based motion capture, fluoroscopy), EMG
and force data with quantitative cartilage parameters derived from advanced
imaging techniques, to yield precise and accurate measures of intra-articular
forces and tissue stress distributions. We will then evaluate the associations
between these measures and pathophysiological measures (e.g., subchondral bone
metabolism and structural OA features) derived from positron emission
tomography - magnetic resonance imaging (PET/MRI) over a 2-year period.
We will evaluate test-retest reliability of our biomechanical data collection
protocol and processing pipelines and assess the sensitivity of our models to
changes of input parameters. We will validate a MRI-based method of
image-registration against a CT-based method.
We will assess the correlation between subchondral bone metabolism and
structural progression of OA. Finally, we aim to explore associations between
our biomechanical parameters and other relevant variables including patient
demographics, physical examination tests, and self-reported outcomes like pain.
The purpose of these analyses will be hypothesis-generating in nature.
Study design
This study includes a technical development phase and a 2-year prospective
observational study.
Study burden and risks
Participants involved in the technical development will attend a single visit
involving biomechanical assessment, photon-counting CT (PCCT) and MR image
acquisition. They will be exposed to a maximum total radiation of 0.07 mSv.
Those in the prospective study will be physically assessed at baseline and
2-year follow-up and fill out questionnaires at 1-year follow-up.
The physical visits will include biomechanical assessment (performing walking
and lunging tasks), PET/MR image acquisition, physical examination, completion
of questionnaires, and blood draw. Total radiation exposure will not exceed
2.47 mSv. Time for data collection will be approximately 4-6 hours at baseline
and 2-year follow-up, divided into two 2-3-hour visits.
At the one year follow-up, questionnaires will take approximately 30 minutes to
complete, these will be performed remotely. In total, the time commitment for 4
visits plus completion of questionnaires at home will be 8-13 hours
Dr. Molewaterplein 40
Rotterdam 3015 GD
NL
Dr. Molewaterplein 40
Rotterdam 3015 GD
NL
Listed location countries
Age
Inclusion criteria
Part 1
Eligible participants will meet the following criteria:
(i) aged 18 years or older;
(ii) never diagnosed with KOA;
(iii) no pain in the ankles, knees, hips or low back for at least 6 months;
(iv) no other diagnosed conditions that might impact mobility (e.g.
inflammatory conditions, cancer, neurologic conditions); and
(v) no contraindications to radiation exposure or MRI.
Part 2. Eligible participants will belong to one of the following three
populations:
• Post-ACLR group:
(i) aged 18-45 years;
(ii) unilateral ACLR; between 12 and 18 months post-ACLR, with or without
concomitant meniscal injuries;
(iii) condition of index knee is stable;
(iv) no complaints in contralateral knee (e.g., no pain, no history of injury);
(v) no early KOA symptoms (no joint line tenderness, no pain while walking or
climbing stairs);
(vi) no radiographic OA (defined as Kellgren and Lawrence grade >= 2) on most
recent radiograph if available
(vii) no history of knee dislocation/multi-ligament injury.
• Early knee OA group:
(i) aged 45-65 years;
(ii) body mass index (BMI) between 27 - 35 kg/m2;
(iii) knee pain aggravated by weight-bearing activities for at least 6 months,
but no longer than 2 years;
(iv) no history of traumatic knee injury (defined as injury that required
non-weight-bearing for >24 hours (e.g. fracture, dislocation, complete ligament
rupture);
(v) no previous knee surgery.
• No OA group, matched to early OA participants on sex and age:
(i) aged 45-65 years;
(ii) never diagnosed with KOA;
(iii) no pain in the ankles, knees, hips or low back for at least 6 months;
(iv) no history of traumatic knee injury (defined as injury that required
non-weight-bearing for >24 hours (e.g. fracture, dislocation, complete ligament
rupture);
(v) no previous knee surgery.
Exclusion criteria
Part 1
(i)diagnosed with KOA;
(ii) pain in the ankles, knees, hips or low back for at least 6 months;
(iii) other diagnosed conditions that might impact mobility (e.g. inflammatory
conditions, cancer, neurologic conditions); and
(iv) contraindications to radiation exposure or MRI.
Part 2
• Morning stiffness in the index knee lasting more than 30 minutes
• Complaints of knee locking
• Any other diagnosed or expected conditions that might impact the
participant*s gait pattern (e.g.,
inflammatory conditions, cancer, neurologic conditions)
• Musculoskeletal conditions affecting the ankles or hips, such as
osteoarthritis or inflammatory arthritis
• Body mass index > 35 kg/m2
• Contraindications to PET/MRI
• Known renal insufficiency
• Known allergy or contraindications to contrast agents
• Contraindications to radiation exposure
• Use of bisphosphonates
• Unable to communicate in either Dutch or English
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL87368.078.24 |